KEMSA Appoint Terry Ramadhani Kiunge as the New CEO

The Kenya Medical Supplies Authority (KEMSA) has appointed Ms Terry Ramadhani Kiunge as the new Chief  Executive Officer at the Authority with immediate effect.

The appointment resulted from a competitive recruitment process undertaken by the Board, which has been ongoing since March 2022.

Among the several applicants who expressed an interest in serving as the KEMSA CEO, Ms Kiunge emerged as the best candidate.

She will now assume organisation leadership, taking over from Mr John Kabuchi, who has been serving in an acting capacity.

She will also effectively replace the outgoing substantive CEO, Dr Jonah  Manjari, whose contract expires next month.

Ms Terry Ramadhani Kiunge is a Seasoned human resources Management practitioner with over 19 years of experience in the fields of Human Resource  Development, organisational transformation, process re-engineering and implementation.

She holds a Master in Business Administration (MBA) from the University of  Liverpool, Adaptive Leadership Certification from the Harvard Kennedy School and a Bachelor of Education from Kenyatta University. She is a certified project management professional and a member of the Chartered Institute of  Personnel and Development (CIPD).

ALSO READ: EABL Gives 100 Million Shillings To Elephants

She has held several strategic and leadership positions in the health sector,  both in the Public and Private sectors.

Before her KEMSA appointment, Ms Kiunge served as the Aga Khan University  Director Academy HR and Global Change. She has also previously worked as a Senior Director at the President’s Delivery Unit (PDU). At PDU, she provided essential project management, monitoring and evaluation support for several national government Health pillar flagship projects, including the Universal  Health Coverage (UHC).

She also previously served as a KEMSA Board Member and extended invaluable support to the Board and Management.

In Ms Kiunge, the KEMSA Board is confident that the organisational transformation agenda will be sustained and professionally executed. The  Board is united in its resolve to facilitate the proper positioning of KEMSA as an effective Health Products and Technologies (HPTs) supply chain provider in the local public health space.

Therefore, the new KEMSA CEO will be expected to spearhead and sustain the necessary reforms to guarantee ethical and cost-effective operations.